Swiss Pharmaceuticals Poison 300 g – High-Stim Pre-Workout

Product guide · Restricted substance

Swiss Pharmaceuticals Poison 300 g – High Stim Pre-Workout Formula

Swiss Pharmaceuticals

Stimulant formula from Swiss Pharmaceuticals, 300 g of powder. This guide sets out what the manufacturer states about the composition of Swiss Pharmaceuticals Poison 300 g, what independent research says about its main ingredients, and the safety and regulatory points that apply. It contains substances that are not authorised as food or medicine in the EU. This guide is educational: it does not recommend use and gives no directions for use.

Educational guide · Sources checked 4 November 2026 · 11 references

Back to the product
Named ingredients
6
Amounts stated
None
Status
Restricted substance
Evidence summaries
5

Overview

Manufacturer information

Ingredients & composition

Manufacturer information
IngredientAmount
Citrulline malateNot stated
Agmatine sulfateNot stated
N-acetyl tyrosineNot stated
Huperzine ANot stated
CaffeineNot stated
Other stimulant compounds (not named)Not stated

The manufacturer does not state the amount of any ingredient. Without amounts, the research summarised in this guide cannot be related to this product's dose.

Not covered in detail in this guide: Other stimulant compounds (not named).

Scientific background

Independent research

L-citrulline and citrulline malate

L-citrulline is an amino acid that the body converts to arginine, a precursor of nitric oxide, which widens blood vessels. Citrulline malate combines citrulline with malic acid1.

Agmatine sulfate

Agmatine is formed in the body from the amino acid arginine and acts as a signalling molecule in the nervous system. It is sold as agmatine sulfate in sports and nootropic products.

L-tyrosine

L-tyrosine is an amino acid that the body uses to make the neurotransmitters dopamine and noradrenaline. It is found in protein-rich foods; N-acetyl-L-tyrosine is a related form2.

Huperzine A

Huperzine A is an alkaloid from the club moss Huperzia serrata. It inhibits acetylcholinesterase, the enzyme that breaks down the neurotransmitter acetylcholine, and it has been used as a medicine for dementia in China3.

Caffeine

Caffeine is a stimulant that blocks adenosine receptors in the brain, reducing perceived effort and fatigue. It is found in coffee, tea and energy drinks and is a common ingredient in pre-workout products4.

Dicaffeine malate (sold as Infinergy®) is caffeine bonded to malic acid. Its caffeine adds to the total caffeine in a product, but labels do not always state the caffeine equivalent.

Research evidence

Independent research

L-citrulline and citrulline malate

A review of human studies found that citrulline supplementation raises plasma arginine, and that several studies report improved exercise performance or recovery, but the results are inconsistent1.

Agmatine sulfate

Controlled human research on agmatine for exercise performance is very limited. Published human data are mostly small studies and a long-term case report5.

L-tyrosine

A review found that tyrosine may support cognitive performance in short-term stressful or cognitively demanding situations, when these neurotransmitters are temporarily depleted, but found no consistent effect on physical exercise performance2.

Huperzine A

A Cochrane review found some benefit on cognitive function in people with Alzheimer's disease, but only one study was of adequate quality and size, so there was inadequate evidence to recommend its use3. A Cochrane review in mild cognitive impairment found the evidence insufficient6.

There is no good evidence that huperzine A improves focus or performance in healthy people.

Caffeine

The International Society of Sports Nutrition concludes that caffeine consistently improves exercise performance when consumed in doses of about 3–6 mg per kg of body mass, with benefits for muscular endurance, movement velocity, strength, sprinting, jumping and aerobic exercise4.

Evidence limitations

Independent research

This product does not state all ingredient amounts, so the doses used in research cannot be compared with what one serving provides.

The studies summarised in this guide examined single ingredients. No published study has tested this product or this combination of ingredients.

L-citrulline and citrulline malate

Studies differ in dose, form (citrulline or citrulline malate, often with an unverified ratio) and exercise test, and many are small. The mechanism behind any performance effect is not established1.

Agmatine sulfate

There are no large randomised trials showing a performance benefit from agmatine in healthy people. Claims of better "pump" or focus are not established.

L-tyrosine

Most studies are small and use single doses in laboratory settings2.

Huperzine A

The trials are mostly small, of limited quality and in people with cognitive disease, so they do not apply to healthy users36.

Caffeine

Responses vary widely between people, partly because of genetics and habitual caffeine use. Many studies use pure caffeine, so results do not automatically apply to multi-ingredient products4.

Safety & potential risks

Independent research

L-citrulline and citrulline malate

Citrulline is generally well tolerated in the doses studied. Digestive discomfort has been reported, and people taking blood-pressure or erectile-dysfunction medication should ask a doctor, because citrulline raises arginine and nitric oxide production1.

Agmatine sulfate

A case report described 5 years of high daily agmatine intake without detected adverse effects5. One case report cannot establish safety for the wider population.

L-tyrosine

People taking MAO inhibitors or thyroid medication should not use tyrosine supplements without medical advice.

Huperzine A

As an acetylcholinesterase inhibitor, huperzine A can cause nausea, diarrhoea, sweating and a slow heart rate, and it may interact with medicines that affect acetylcholine or heart rate. Anyone taking medication or with heart, lung or digestive conditions should ask a doctor first.

Caffeine

EFSA concluded that single doses of up to 200 mg, and daily intakes of up to 400 mg from all sources, do not raise safety concerns for healthy adults. For pregnant and breastfeeding women, daily intakes up to 200 mg do not raise concerns for the foetus or infant7.

Higher intakes can cause anxiety, sleep disturbance, raised heart rate and blood pressure, and digestive upset. Combining several caffeine sources (coffee, energy drinks, pre-workouts) raises total intake74.

Regulatory status

GIGACULT product information

This product contains an ingredient that is restricted or not authorised as a food supplement in some or all EU markets. No health benefits or directions for use are given.

Regulation and sport

L-citrulline and citrulline malate

L-citrulline is used in EU food supplements under national rules. No health claim for citrulline is authorised in the EU8.

Agmatine sulfate

Agmatine sulfate is used in some EU food supplements under national rules. No health claim is authorised8. Whether a product needs novel food authorisation depends on its history of use9.

L-tyrosine

Amino acids such as L-tyrosine are used in EU food supplements under national rules. No health claim is authorised8.

Huperzine A

Huperzine A is a pharmacologically active substance. Its status as a food ingredient is not harmonised in the EU, and some Member States treat it as a medicinal substance109.

Caffeine

Caffeine is permitted in EU foods and food supplements, subject to labelling rules. It is not on the World Anti-Doping Agency Prohibited List11.

Scientific references

  1. Gonzalez AM, Trexler ET. Effects of citrulline supplementation on exercise performance in humans: a review of the current literature. J Strength Cond Res. 2020;34:1480-1495. PubMed 31977835
  2. Jongkees BJ, Hommel B, Kühn S, et al. Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands: a review. J Psychiatr Res. 2015;70:50-57. PubMed 26424423
  3. Li J, Wu HM, Zhou RL, et al. Huperzine A for Alzheimer's disease. Cochrane Database Syst Rev. 2008;(2):CD005592. PubMed 18425924
  4. Guest NS, VanDusseldorp TA, Nelson MT, et al. International Society of Sports Nutrition position stand: caffeine and exercise performance. J Int Soc Sports Nutr. 2021;18:1. PubMed 33388079
  5. Gilad GM, Gilad VH. Long-term (5 years), high daily dosage of dietary agmatine: evidence of safety: a case report. J Med Food. 2014;17:1256-1259. PubMed 25247837
  6. Yue J, Dong BR, Lin X, et al. Huperzine A for mild cognitive impairment. Cochrane Database Syst Rev. 2012;12:CD008827. PubMed 23235666
  7. EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on the safety of caffeine. EFSA Journal. 2015;13(5):4102. DOI 10.2903/j.efsa.2015.4102
  8. Commission Regulation (EU) No 432/2012 establishing a list of permitted health claims made on foods. Official Journal of the European Union. Source
  9. Regulation (EU) 2015/2283 on novel foods. Official Journal of the European Union. Source
  10. Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official Journal of the European Union. Source
  11. World Anti-Doping Agency. The Prohibited List (current edition). Source

Sources checked against PubMed, Crossref or the official publisher on 2026-11-04. Manufacturer information is taken from the product's own data and has not been independently tested.

The product

Swiss Pharmaceuticals Poison 300 g – High Stim Pre-Workout Formula

€49,90

View product